Tech Company Financing Transactions
Dimension Therapeutics Funding Round
Dimension Therapeutics closed a $30 million funding round on 6/23/2014. Backers included F-Prime Capital and OrbiMed.
Transaction Overview
Company Name
Announced On
6/23/2014
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Undisclosed
Investors
F-Prime Capital (Benjamin Auspitz)
OrbiMed (Rishi Gupta)
Proceeds Purpose
Rishi and the OrbiMed team will be valuable partners and strategic advisors as we continue to advance our novel gene therapy programs for patients with rare diseases.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
840 Memorial Drive
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Dimension Therapeutics, Inc., is a leading rare disease company focused on developing novel treatments for devastating disorders associated with the liver and based on an industry-leading, extensively validated adeno-associated virus (AAV) platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Annalisa Jenkins
Chief Financial Officer
Jean Franchi
Chief Medical Officer
Eric Crombez
Chief Scientific Officer
Sam Wadsworth
VP - Bus. Development
Andy Hu
VP - Human Resources
Rachel Strauss
VP - Manufacturing
Reed Clark
VP - Operations
Stephanie Haller
VP - Regulatory Affairs
Khandan Baradaran
Browse more venture capital transactions:
Prev: 6/23/2014: AnyPerk venture capital transaction
Next: 6/23/2014: Patreon venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are derived from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs